Xiangye Liu

209 Tongshan Road
Xuzhou, 221004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Correction: Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2.

Correction: Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2.

Journal: Cancer immunology, immunotherapy : CII

Published: August 19, 2026

A commensal protozoan exacerbates acetaminophen-induced liver injury by producing free sphingosine.

A commensal protozoan exacerbates acetaminophen-induced liver injury by producing free sphingosine.

Journal: Gut microbes

Published: June 03, 2026

HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A.

HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A.

Journal: Cancer biology & medicine

Published: May 20, 2026

RNA splicing regulation and tumor: A focus on the multifunctional SRSF family as a therapeutic target.

RNA splicing regulation and tumor: A focus on the multifunctional SRSF family as a therapeutic target.

Journal: Biochemical pharmacology

Published: February 11, 2026

Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2.

Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2.

Journal: Cancer immunology, immunotherapy : CII

Published: December 05, 2025

HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression.

HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression.

Journal: Hepatology communications

Published: September 26, 2024

4-Hydroxybenzoic acid restrains Nlrp3 inflammasome priming and activation via disrupting PU.1 DNA binding activity and direct antioxidation.

4-Hydroxybenzoic acid restrains Nlrp3 inflammasome priming and activation via disrupting PU.1 DNA binding activity and direct antioxidation.

Journal: Chemico-biological interactions

Published: June 25, 2024

Molecular mechanism of co-stimulatory domains in promoting CAR-T cell anti-tumor efficacy.

Molecular mechanism of co-stimulatory domains in promoting CAR-T cell anti-tumor efficacy.

Journal: Biochemical pharmacology

Published: May 14, 2024

Delta-Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway.

Delta-Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway.

Journal: Molecular carcinogenesis

Published: February 21, 2024

Immunotherapy and drug sensitivity predictive roles of a novel prognostic model in hepatocellular carcinoma.

Immunotherapy and drug sensitivity predictive roles of a novel prognostic model in hepatocellular carcinoma.

Journal: Scientific reports

Published: February 20, 2024

Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity.

Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity.

Journal: BMC cancer

Published: April 19, 2023

Antimicrobial and Anti-Inflammatory Activities of MAF-1-Derived Antimicrobial Peptide Mt6 and Its D-Enantiomer D-Mt6 against Acinetobacter baumannii by Targeting Cell Membranes and Lipopolysaccharide Interaction.

Antimicrobial and Anti-Inflammatory Activities of MAF-1-Derived Antimicrobial Peptide Mt6 and Its D-Enantiomer D-Mt6 against Acinetobacter baumannii by Targeting Cell Membranes and Lipopolysaccharide Interaction.

Journal: Microbiology spectrum

Published: October 03, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026